Immunogenicity and Safety of Sanofi Pasteur's AVAXIM 80U Pediatric Vaccine Followed by Booster Dose
Clinical trial NCT00483470 · COMPLETED
Trial details
- NCT number
- NCT00483470
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-06-01
- Primary completion
- 2008-05-01
- Enrollment
- 720
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.